Access for Life's vision is to facilitate therapies that require repetitive vein access for chronic disease patients.  Our patented platform, comprised of the JEM™ implanted sensor-enhanced device and electronic pack, preserves vein health while it reduces the rate of clinical complications due to vessel wall damage, e.g. perforation, pseudoaneurysms, and hematomas  and provides for the first time, real-time data collection on the dialysis process.  The JEM™ platform ensures easier and safer cannulation, thereby greatly encouraging self-cannulation and home hemodialysis.

© 2019 by Access for Life. Proudly created with

  • LinkedIn Basic Black
  • Twitter Basic Black